Literature DB >> 13106710

Pediatric endocrinology; notes on some recent advances.

F L PLACHTE.   

Abstract

Until recently, congenital adrenocortical hyperplasia has defied most medical and surgical therapeutic efforts. However, in properly selected patients, cortisone will suppress the abnormal cortical hormone production. This, in turn, will lead to previously inhibited maturation and developmental progress. Adrenocortical insufficiency calls for much diagnostic alertness, as early recognition and immediate treatment are of paramount importance. The available therapeutic means are beneficial, although their limitations and potential dangers should be heeded.Among newly developed diagnostic techniques, thyrograms promise to be helpful in the study of thyroid hyperplasia and neoplasia. Thyroid cancer, occurring infrequently in childhood, should at the earliest possible time be treated surgically and with postoperative radiation therapy.

Entities:  

Keywords:  ENDOCRINOLOGY; HYPERTROPHY AND HYPERPLASIA; PEDIATRIC DISEASES

Mesh:

Substances:

Year:  1953        PMID: 13106710      PMCID: PMC1521920     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  29 in total

1.  Metabolic studies in patients with congenital adrenal hyperplasia; effects of cortisone therapy.

Authors:  V C KELLEY; R S ELY; R B RAILE
Journal:  J Clin Endocrinol Metab       Date:  1952-05       Impact factor: 5.958

2.  Further studies on the treatment of congenital adrenal hyperplasia with cortisone. IV. Effect of cortisone and compound B in infants with disturbed electrolyte metabolism.

Authors:  J F CRIGLER; S H SILVERMAN; L WILKINS
Journal:  Pediatrics       Date:  1952-10       Impact factor: 7.124

3.  Carcinoma of the thyroid gland in youth.

Authors:  R C HORN; I S RAVDIN
Journal:  J Clin Endocrinol Metab       Date:  1951-10       Impact factor: 5.958

4.  Further studies on the treatment of congenital adrenal hyperplasia with cortisone. I. Comparison of oral and intramuscular administration of cortisone, with a note on the suppressive action of compounds F and B on the adrenal.

Authors:  L WILKINS; L I GARDNER; J F CRIGLER; S H SILVERMAN; C J MIGEON
Journal:  J Clin Endocrinol Metab       Date:  1952-03       Impact factor: 5.958

5.  Adrenogenital syndrome with associated episodes of hypoglycemia.

Authors:  F P WHITE; L E SUTTON
Journal:  J Clin Endocrinol Metab       Date:  1951-11       Impact factor: 5.958

6.  Case of adrenogenital syndrome with hypertension treated with cortisone.

Authors:  T H SHEPARD; S W CLAUSEN
Journal:  Pediatrics       Date:  1951-12       Impact factor: 7.124

7.  Treatment of congenital adrenal hyperplasia with cortisone.

Authors:  L WILKINS; R A LEWIS; R KLEIN; L I GARDNER; J F CRIGLER; E ROSEMBERG; C J MIGEON
Journal:  J Clin Endocrinol Metab       Date:  1951-01       Impact factor: 5.958

8.  Abnormalities in the secretion of the adrenal cortex during early life.

Authors:  W C DEAMER; H K SILVER
Journal:  J Pediatr       Date:  1950-10       Impact factor: 4.406

9.  Carcinoma of the thyroid in children; a 10 year follow-up.

Authors:  H F HARE; R V NEWCOMB
Journal:  Radiology       Date:  1950-03       Impact factor: 11.105

10.  Thyrotropic hormone in infants and children; differentiation between primary and hypopituitary hypothyroidism.

Authors:  D E PICKERING; E R MILLER
Journal:  AMA Am J Dis Child       Date:  1953-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.